Ingredients used by Johnson & Johnson in some of the 40 varieties of children's cold medicines recalled last week were contaminated with bacteria, according to a report by the Food and Drug Administration.
Swiss pharmaceutical company Novartis AG is paying $72.5 million to settle a whistleblower lawsuit accusing it of improperly billing government programs for unapproved uses of a cystic fibrosis drug.
Thermo Fisher Scientific Inc. announced that its NanoDrop 2000c UV-Vis Spectrophotometer significantly improves the protein quantitation process.
G-Biosciences offers a large selection of coated 96-well plates, known as Well-Coated plates.
Warnex Medical Laboratories, a division of Warnex Inc., and Epigenomics AG, have entered into a non-exclusive licensing agreement for Epigenomics' colorectal cancer biomarker Septin9.
Bristol-Myers Squibb Company announced its Board of Directors has authorized the repurchase of up to $3 billion of its common stock.
A compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells--the small number of cells that fuel a tumor's growth--according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
At first glance, cancer and neurodegenerative diseases seem to have little in common, but the more that is learned about the signaling pathways that control cell division, differentiation, neuronal plasticity and cell death, the more apparent is the overlap between the two types of disease.
Currently under FDA review, CS-8635 combines three powerful blood pressure treatments with different mechanisms of action, Benicar (olmesartan medoxomil), amlodipine and hydrochlorothiazide.
Cempra Pharmaceuticals announced positive results from its Phase 2 clinical trial evaluating the efficacy and tolerability of the novel front loading dosing regimen of TAKSTA, the company’s oral, anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotic.
The Food and Drug Administration is looking into data suggesting a group of prostate cancer drugs increase the risk of diabetes and heart disease.
An Albuquerque woman has filed a lawsuit over a vaccine intended to protect women from cervical cancer, alleging it caused physical and behavioral problems in her teenage daughter.
Gilead Sciences, Inc. has obtained data supporting bioequivalence of a formulation of the fixed-dose combination of Truvada and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278.
Thermo Fisher Scientific Inc. announced the latest release in its GRAMS Suite of spectroscopy software, an industry standard solution for visualizing, processing, reporting and managing spectroscopy data.
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.